Indiana Code 16-42-22-8. Requirements for substitution
Current as of: 2023 | Check for updates
|
Other versions
Sec. 8. (a) For substitution to occur for a prescription other than a prescription filled under the Medicaid program (42 U.S.C. § 1396 et seq.), the children’s health insurance program established under IC 12-17.6-2, the biosimilar biological products requirements under IC 16-42-25, or the Medicare program (42 U.S.C. § 1395 et seq.):
(A) sign on the line under which the words “May substitute” appear; or
(1) the practitioner must:
Terms Used In Indiana Code 16-42-22-8
- customer: means the individual for whom a prescription is written or electronically transmitted or the individual's representative. See Indiana Code 16-42-22-3
- generically equivalent drug product: means a multiple source drug product:
Indiana Code 16-42-22-4
- practitioner: means any of the following:
Indiana Code 16-42-22-4.5
- substitute: means to dispense a generically equivalent drug product in place of the brand name drug product prescribed by the practitioner. See Indiana Code 16-42-22-5
(B) for an electronically transmitted prescription, electronically transmit the instruction “May substitute.”; and
(2) the pharmacist must inform the customer of the substitution.
(b) This section does not authorize any substitution other than substitution of a generically equivalent drug product.
[Pre-1993 Recodification Citation: 16-6-8.1-2(c).]
As added by P.L.2-1993, SEC.25. Amended by P.L.239-1999, SEC.7; P.L.291-2001, SEC.233; P.L.204-2005, SEC.10; P.L.96-2014, SEC.5.